---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-22-010697"
form_type: "8-K"
ticker: "VTGN"
cik: "0001411685"
company_name: "Vistagen Therapeutics, Inc."
filed_at: "2022-05-03T23:59:59+00:00"
generated_at: "2026-06-26T01:22:40.072221+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# VistaGen appoints Reid Adler as Chief Legal Officer effective May 2, 2022

## Summary
- Reid G. Adler appointed CLO; will oversee legal affairs and provide strategic guidance to Executive Team and Board.
- Adler previously founded Capital Technology Law Group and had represented VistaGen as outside counsel.
- Career includes partner at Morrison & Foerster and Morgan Lewis, general counsel at J. Craig Venter Institute.
- Adler was founding director of NIH Office of Technology Transfer, building a team of over 40 people.
- Company paid Capital Technology Law Group $210,000 in FY ended March 2022 and $18,000 in April 2022 for legal services.

## SEC filing metadata
- accession: 0001437749-22-010697
- form_type: 8-K
- ticker: VTGN
- cik: 0001411685
- company_name: Vistagen Therapeutics, Inc.
- filed_at: 2022-05-03T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1411685/000143774922010697/0001437749-22-010697-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1411685/000143774922010697/vtgn20220502_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-22-010697
- JSON: https://secwatch.observer/filing/0001437749-22-010697.json
- Plain text: https://secwatch.observer/filing/0001437749-22-010697.txt

## Key facts
- Executive change
  Reid G. Adler was appointed as Chief Legal Officer at Vistagen Therapeutics, Inc..
  - Action: appointed
  - Role: Chief Legal Officer
  source text: On May 2, 2022, the Board of Directors (the “ Board ”) of VistaGen Therapeutics, Inc. (the “ Company ”), appointed Mr. Reid G. Adler, age 67, as the Company’s Chief Legal Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1411685/000143774922010697/0001437749-22-010697-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.